Physician profile
Rick T Chac
NPI 1538347760
$1,583.30
in general payments reported to CMS, 2019-2025
15 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $75.89 · 2021: $451 · 2022: $191 · 2023: $157 · 2024: $374 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.71 |
| Education | $109.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $296.98 | 2021-2024 | |
| Avion Pharmaceuticals | $209.89 | 2021 | |
| Astellas Pharma US INC | $197.74 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $176.41 | 2023-2024 | Myfembree |
| Allergan, INC. | $158.72 | 2019-2020 | |
| Abbvie INC. | $157.48 | 2020-2022 | |
| Boston Scientific Corporation | $120.48 | 2024 | Versacross Access Solution |
| Myovant Sciences INC. | $64.48 | 2021-2022 | |
| Hologic Sales and Service, LLC | $54.92 | 2020-2024 | Novasure, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $35.10 | 2021-2022 | |
| Therapeuticsmd, INC. | $33.40 | 2021-2022 | |
| Organon LLC | $32.39 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $19.42 | 2020 | |
| Medicem INC. | $13.60 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Chac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.